News & Analysis as of August 17, 2025

Government Agencies

+ Follow

Medicaid is a partnership program between states and the federal government to provide healthcare coverage for lower income individuals, people with disabilities, older people, and certain families with... more +

340B Drug Pricing Program Is on a Slippery Slope

Shipman & Goodwin LLP on 8/5/2025

On July 31, 2025, notice was published in the Federal Register by the Health Resources and Services Administration (“HRSA”) of a “340B Rebate Model Pilot Program” (“340B Pilot Program”). The 340B Pilot Program’s stated...more

Most-Favored-Nation Drug Pricing in the U.S.

Brownstein Hyatt Farber Schreck on 6/10/2025

On May 12, President Trump issued an Executive Order (EO) on drug pricing: “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” The EO requires a 30-day government negotiation with drug companies...more

Health Headlines: April 2025

Goodwin on 5/1/2025

Welcome to the fifth issue of Health Headlines, a newsletter created by lawyers in our Healthcare practice....more

Healthcare Regulatory Check-Up Newsletter | March 2025 Recap

McDermott Will & Schulte on 4/28/2025

This issue of McDermott’s Healthcare Regulatory Check-Up highlights key regulatory and enforcement activity for March 2025. This month features: - Noteworthy enforcement actions demonstrating that the Anti-Kickback Statute...more

Healthcare & Life Sciences Drug Pricing Digest - April 2025

Latham & Watkins LLP on 4/8/2025

The Latham drug pricing and market access team invites you to read this digest of recent developments on healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law....more

5 Results

View per page